Daridorexant. An expensive pill to help you sleep 18 minutes longer.

Daridorexant. An expensive pill to help you sleep 18 minutes longer.

Insomnia is a nightmare.

We’ve all met the exhausted patient who is close to breaking point, desperate for a solution. You’re heart sinks as the solution is often complex, and you know that it will be a challenge, requiring multiple appointments. My training consisted of counselling patients on sleep hygiene, behavioural interventions, and addressing underlying causes. We clamped down on Zopiclone scripts and mother’s little helpers. We told patients that there was no magic pill.

Apparently, that was all rubbish. There is a magic pill after all! Crack open the emergency bubbly, Big Pharma is here to save the day!

NICE has now approved Daridorexant, a drug that blocks orexin, one of the brain’s wakefulness chemicals. It arrives with plenty of excitement, plenty of marketing, and a price tag of around £120 for a three-month course.

But does it actually work?

The study

The evidence comes from two multicentre, randomised, double-blind, placebo-controlled phase III trials published in The Lancet Neurology.

Patients with insomnia disorder were randomised to receive either daridorexant or placebo.

The primary outcomes were:

  • Wake After Sleep Onset (WASO)
  • Latency to Persistent Sleep (LPS)

In plain English, how long patients lay awake during the night and how quickly they got to sleep.

Results

If you’re terribly bourgeoise, and actually opened a bottle of Champagne in celebration, I would suggest that you put a spoon in it and go make a cup of tea. The results are rubbish.

After three months:

  • Patients taking daridorexant spent approximately 18 fewer minutes awake at night compared with placebo.
  • Patients fell asleep approximately 12 minutes faster than those receiving placebo.

The results were statistically significant.

I don’t think a few minutes is clinically significant though. I’ve never had a patient come in asking for 18 more minutes of sleep.

The Devil’s in the detail.

If you think, “Ah sod it, it will get them out the door quickly”, I’d suggest you look at their inclusion and exclusion criteria.

The trials excluded many of the patients we commonly see in General Practice. This trick is a favourite of Big Pharma and is called selection bias; they exclude all those difficult to treat folk, in the hope that the results will be more favourable.

Patients with significant psychiatric illness were excluded.

Patients taking antidepressants were excluded.

Many important chronic medical conditions were excluded.

Participants were recruited through specialist sleep centres rather than primary care.

Consequently, the population studied looks rather different from the average patient presenting to a GP with insomnia.

Think about how many of your insomnia patients also have anxiety, depression, chronic pain, diabetes, COPD, cardiovascular disease, caring responsibilities, financial worries, or teenagers arriving home at 2am.

Now think about how many don’t.

A note on the power of the consultation.

Now, I’m no Dr Roger Neighbour, but when has a lack of knowledge stopped a white male from talking about something that they are not an expect on. I think this study highlights the power of the consultation. Even without a fancy expensive pill, the placebo group’s results also improved considerably. At three months, insomnia severity scores had fallen by 5.4 points in the placebo arm, compared with 7.2 points in the Daridorexant arm. A helpful reminder that good, in depth reviews help people.

The takeaway

Daridorexant is rubbish.

It can cause worsening depression, addiction and suicidal ideation. Anyone remember that do no harm thing?

NICE themselves had significant concerns about the evidence and cost, so they initially didn’t approve these magic beans. Yet in true NICE style, they signed off on it anyway after the company provided some updated economic models. Now, we all know economic models are terrible. If the models were so good, the modellers would not be working for Big Pharma, they would be swimming in pools of gold like Scrooge McDuck.


Comments

Leave a Reply